サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1748710

エレクトロシューティカルズの世界市場：製品別・種類別・用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)

Electroceuticals Market, By Product, By Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 375 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
エレクトロシューティカルズの世界市場：製品別・種類別・用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)
出版日: 2025年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 375 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

2024年のエレクトロシューティカルズ（電気薬剤）の市場規模は224億5,645万米ドルで、2024年から2032年にかけてCAGR 7.60%で拡大

エレクトロシューティカルズの市場力学

神経疾患の有病率の上昇が需要を牽引

神経疾患の罹患率の増加が、エレクトロシューティカルズ市場の成長に大きく寄与しています。パーキンソン病、てんかん、慢性うつ病、アルツハイマー病、多発性硬化症などの疾患は、人口の高齢化、ライフスタイルの変化、診断能力の向上などの要因により、より一般的になってきています。これらの疾患は治療の選択肢が限られていることが多く、従来の医薬品によるアプローチでは十分な効果が得られなかったり、好ましくない副作用が現れたりすることがあります。その結果、より精度が高く、全身への影響が少ない先進的な治療法へのシフトが進んでいます。エレクトロシューティカルズは、電気刺激によって疾患症状の原因となる神経回路を直接標的とすることで、新しいアプローチを提供します。脳深部刺激療法（DBS）、迷走神経刺激療法（VNS）、脊髄刺激療法（SCS）などの技術は、複雑な神経疾患の管理において大きな成功を収めています。症状のコントロールや患者のQOLが向上することから、これらの機器はヘルスケアプロバイダーや患者の間で人気を集めています。

エレクトロシューティカルズ市場：主な考察

当社のリサーチアナリストによると、世界のエレクトロシューティカルズ市場は、2024年から2032年にかけて約7.60%のCAGRで発展する見込みです。

2023年の製品別セグメントでは、心臓ペースメーカーと植え込み型除細動器カテゴリが市場を独占しています。

種類別では、植え込み型電気治療機器が2023年に最も収益を上げました。

地域別では、2023年に北米が最も高い収益を上げた地域でした。

エレクトロシューティカルズ市場：セグメンテーション分析

世界のエレクトロシューティカルズ市場は、製品別・種類別用途、地域別に分類されます。

エレクトロシューティカルズ市場は、製品別に心臓ペースメーカー・植え込み型除細動器（ICD）、人工内耳、神経調節器、網膜インプラントに区分されます。このうち、心臓ペースメーカー・ICDが市場を独占すると予想されます。この優位性は主に、不整脈や心不全を含む心血管系疾患の世界の有病率の高さによるもので、心臓への電気刺激によるタイムリーな介入が必要です。これらの機器は、その有効性が証明されていること、技術の進歩、心臓疾患にかかりやすい高齢者層での使用の増加などにより、広く採用されています。さらに、先進諸国では償還政策が利用可能であり、低侵襲心臓機器の技術革新が進んでいることも、これらの機器の採用をさらに後押ししています。人工内耳と神経調節器は成長分野ですが、心臓機器は長年にわたる臨床使用、強固なインフラ、救命の可能性により、市場での主導的地位を確保しています。心血管疾患は依然として世界の死亡原因の上位を占めているため、これらの機器に対する需要は引き続き堅調に推移すると予想されます。

電気治療器市場は、種類別に植え込み型電気治療機器と非侵襲性電気治療機器に区分されます。このうち、植え込み型電気治療器が市場で圧倒的なシェアを占めています。この優位性は、心臓不整脈、てんかん、パーキンソン病などの重篤な慢性疾患の治療に広く応用されていることに起因しています。心臓ペースメーカー、植え込み型除細動器（ICD）、脳深部刺激装置、迷走神経刺激装置などの装置は、高い有効性と長期的な利点を備えた標的療法を提供するため、重篤な病状に適した選択肢となっています。植え込み型機器は、小型化、バッテリー技術、機器プログラミングの継続的な進歩の恩恵も受け、安全性と性能が向上しています。さらに、新興国市場で長年にわたって臨床的に受け入れられ、償還制度がしっかりしていることも、より広範な普及を後押ししています。非侵襲的なデバイスは軽度の症状や在宅療法で支持を集めていますが、植え込み型エレクトロシューティカルズはその治療精度と救命用途により、引き続き市場をリードしています。

エレクトロシューティカルズ市場：地域別分析

地域的には、エレクトロシューティカルズ市場は北米、アジア太平洋、ラテンアメリカ、欧州、中東・アフリカに分布しています。これらの地域は、ビジネスをもたらしている国に基づいてさらに分割されます。

北米は世界のエレクトロシューティカルズ市場で最大のシェアを占めており、米国が主要な貢献国です。この地域は、強固なヘルスケア・インフラ、高いヘルスケア支出、先進医療技術の急速な導入などの恩恵を受けています。パーキンソン病、てんかん、心血管疾患、難聴などの慢性疾患の有病率が上昇していることが、心臓ペースメーカー、ICD、人工内耳、脳深部刺激装置などの埋め込み型機器に対する一貫した需要を牽引しています。さらに、メドトロニック、アボット、ボストン・サイエンティフィックといった主要市場プレイヤーの存在により、強力な研究開発・商品化パイプラインが確保されています。米国FDAなどの規制機関は、医療機器承認のための明確な枠組みを提供し、技術革新と市場参入を促進しています。さらに、有利な償還政策と医師や患者の意識の高まりが、市場の拡大をさらに後押ししています。米国はまた、ニューロモジュレーションやバイオエレクトロニクス医療に焦点を当てた臨床試験や学術研究でもリードしています。カナダは市場規模こそ小さいもの、公的ヘルスケアへの取り組みや先進治療へのアクセス向上を通じて貢献しています。この地域は個別化医療、デジタルヘルス統合、小型化された生体電子機器への投資を続けているため、北米は今後数年間、エレクトロシューティカルズの展望におけるリーダーシップを維持すると予想されます。

欧州は、高齢化社会と神経疾患および心血管疾患の罹患率上昇に牽引され、エレクトロシューティカルズの第2位の市場となっています。ドイツ、英国、フランスなどの国々は、先進的なヘルスケア・インフラ、包括的な保険、積極的な規制支援により、主要な収益源となっています。この地域は、脳深部刺激療法、迷走神経刺激療法、人工内耳などの革新的な治療技術を採用する傾向が強いです。欧州には、バイオエレクトロニック医療開発に貢献する著名な学術機関や研究センターがあります。公衆衛生団体と欧州連合の両方からの資金援助が、臨床研究と機器イノベーションの成長を促進しています。さらに、神経調節療法に対する患者の高い認識と臨床医の専門知識が、採用率を高めています。多くの欧州諸国における償還の枠組みは、高コストの医療技術へのアクセスを支援し、それによって電気治療への患者の取り込みを増加させています。

エレクトロシューティカルズ市場：競合情勢

エレクトロシューティカルズ市場は競争が激しく、メドトロニック、ボストン・サイエンティフィック・コーポレーション、アボットなど、広範な研究開発能力、規制に関する専門知識、世界な流通網を活用する既存の医療機器メーカーが優位を占めています。これらの企業は、心臓機器、神経調節、聴覚インプラントなどの革新的なソリューションを通じてポートフォリオを拡大することに注力しています。LivaNova Plc、Cochlear Ltd.、Sonovaは迷走神経刺激や人工内耳のようなニッチ分野に特化し、神経疾患や聴覚障害の患者の転帰を向上させています。一方、Axonics Inc.、Neuronetics、ElectroCore Inc.、NeuroPace Inc.などの新興プレーヤーは、うつ病、てんかん、過活動膀胱などの疾患をターゲットとした低侵襲かつウェアラブルな神経調節技術によって技術革新を推進しています。MicroPort Scientific CorporationとNervo Corp.は、それぞれアジアと北米で事業を拡大しています。戦略的買収、提携、継続的な製品開発を特徴とするこの競合情勢は、技術進歩とエレクトロシューティカルズの国際的普及を促進するダイナミックな環境を育んでいます。

目次

第1章 エレクトロシューティカルズ市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 エレクトロシューティカルズの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 エレクトロシューティカルズ市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 エレクトロシューティカルズ市場： 新型コロナウイルス感染症 (COVID-19) の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 エレクトロシューティカルズの市場情勢

  • エレクトロシューティカルズの市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 エレクトロシューティカルズ市場：製品別

  • 概要
    • セグメント別シェア分析：製品別
    • 心臓ペースメーカー・植え込み型除細動器
    • 人工内耳
    • 神経調節薬
      • 脊髄刺激装置
      • 脳深部刺激装置
      • 迷走神経刺激装置
      • 仙骨神経刺激装置
      • 胃電気刺激装置
      • 経頭蓋磁気刺激装置
      • 呼吸電気刺激装置
      • 三叉神経刺激装置
      • 応答性神経刺激装置
    • 網膜インプラント

第8章 エレクトロシューティカルズ市場：種類別

  • 概要
    • セグメント別シェア分析：種類別
    • 埋め込み型電気治療機器
    • 非侵襲性電気治療機器

第9章 エレクトロシューティカルズ市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 心臓ペースメーカー・植え込み型除細動器 (ICD)
      • 不整脈
      • 心不全
      • その他の心臓ペースメーカー・ICDの用途
    • 脊髄刺激装置
      • 慢性疼痛
      • 背部手術失敗症候群
      • 虚血
    • 脳深部刺激装置 (DBS)
      • パーキンソン病
      • 震え
      • うつ
      • その他のDBSの用途
    • 仙骨神経刺激装置
      • 尿失禁
      • 便失禁
    • 迷走神経刺激装置 (VNS)
      • てんかん
      • その他のVNSの用途
    • 胃電気刺激装置
      • 胃不全麻痺
      • 肥満
    • 経皮的電気神経刺激装置 (TENS)
      • 治療抵抗性うつ病
      • その他のTENSの用途
    • 経頭蓋磁気刺激装置
      • うつ
      • 片頭痛
    • 呼吸電気刺激装置
      • 脊髄損傷
    • 三叉神経刺激装置
      • 注意欠陥・多動性障害 (ADHD)
      • 片頭痛

第10章 エレクトロシューティカルズ市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：エレクトロシューティカルズ業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Medtronic
    • Boston Scientific Corporation
    • Abbott
    • Livanova Plc
    • Cochlear Ltd.
    • Microport Scientific Corporation
    • Sonova
    • Nervo Corp.
    • Axonics Inc.
    • Neuronetics
    • Electrocore Inc.
    • Neuropace Inc.
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV5243

REPORT HIGHLIGHT

Electroceuticals Market size was valued at USD 22,456.45 Million in 2024, expanding at a CAGR of 7.60% from 2024 to 2032.

Electroceuticals, also known as bioelectronic medicines, are a class of therapeutic devices that use electrical impulses to modulate the body's neural circuits, offering an alternative or complement to pharmaceutical treatments. These devices target specific nerves or brain regions to treat various medical conditions, including chronic pain, epilepsy, Parkinson's disease, depression, and even inflammatory disorders. Unlike traditional pharmaceuticals that rely on chemical interactions within the body, electroceuticals operate by influencing the electrical signaling pathways that underlie physiological processes. Typically, electroceutical devices are either implanted or wearable, depending on the condition being treated. For example, deep brain stimulators, vagus nerve stimulators, and spinal cord stimulators are commonly used implantable electroceuticals. These devices deliver precisely controlled electrical signals to alter abnormal nerve activity, helping to restore normal function or alleviate symptoms. Recent advancements in neuroscience, bioengineering, and miniaturization have driven innovation in this field, enabling more targeted and less invasive treatments. Electroceuticals are considered promising in areas where conventional drug therapies may fall short due to side effects, limited efficacy, or resistance. By harnessing the body's electrical system, electroceuticals open up new possibilities for personalized and precise medical interventions, potentially transforming the way chronic diseases are managed in the future.

Electroceuticals Market- Market Dynamics

Rising Prevalence of Neurological Disorders Driving Demand

The increasing incidence of neurological disorders is significantly contributing to the growth of the electroceuticals market. Conditions such as Parkinson's disease, epilepsy, chronic depression, Alzheimer's disease, and multiple sclerosis are becoming more prevalent due to factors like aging populations, lifestyle changes, and improved diagnostic capabilities. These disorders often have limited treatment options, and conventional pharmaceutical approaches may lead to inadequate results or undesirable side effects. As a result, there is a growing shift toward advanced therapeutic solutions that offer greater precision and fewer systemic impacts. Electroceuticals provide a novel approach by directly targeting neural circuits responsible for disease symptoms through electrical stimulation. Technologies such as deep brain stimulation (DBS), vagus nerve stimulation (VNS), and spinal cord stimulation (SCS) have shown considerable success in managing complex neurological conditions. With better outcomes in symptom control and patient quality of life, these devices are gaining traction among healthcare providers and patients alike.

ELECTROCEUTICALS Market- Key Insights

According to our research analyst, the global Electroceuticals Market is expected to develop at a CAGR of approximately 7.60% between 2024-2032.

Segmented by Product in 2023, the Cardiac Pacemakers & Implantable Cardioverter Defibrillators category dominated the market.

Based on type, the Implantable Electroceutical Devices generated the most income in 2023.

Based on region, in 2023, North America was the region with the highest revenue.

Electroceuticals Market- Segmentation Analysis:

The global Electroceuticals market is divided into three categories: product, type, application and region.

The electroceuticals market is segmented by product into Cardiac Pacemakers & Implantable Cardioverter Defibrillators (ICDs), Cochlear Implants, Neuromodulators, and Retinal Implants. Among these, Cardiac Pacemakers & ICDs are expected to dominate the market. This dominance is primarily driven by the high global prevalence of cardiovascular diseases, including arrhythmias and heart failure, which require timely intervention through electrical stimulation of the heart. These devices are widely adopted due to their proven efficacy, technological advancements, and increasing use in aging populations who are more susceptible to heart conditions. Additionally, the availability of reimbursement policies in developed countries and ongoing innovation in minimally invasive cardiac devices further boost their adoption. While cochlear implants and neuromodulators are growing segments, the long-standing clinical use, robust infrastructure, and life-saving potential of cardiac devices secure their leading position in the market. As cardiovascular diseases remain a leading cause of mortality worldwide, demand for these devices is expected to remain strong.

By type electroceuticals market is segmented into Implantable Electroceutical Devices and Noninvasive Electroceutical Devices. Among these, Implantable Electroceutical Devices hold the dominant share of the market. This dominance is attributed to their widespread application in treating critical, chronic conditions such as cardiac arrhythmias, epilepsy, and Parkinson's disease. Devices like cardiac pacemakers, implantable cardioverter defibrillators (ICDs), deep brain stimulators, and vagus nerve stimulators offer targeted therapy with high efficacy and long-term benefits, making them the preferred choice for severe medical conditions. Implantable devices also benefit from continuous advancements in miniaturization, battery technology, and device programming, which enhance their safety and performance. Furthermore, their long-standing clinical acceptance and robust reimbursement frameworks in developed markets support broader adoption. Although noninvasive devices are gaining traction for mild conditions and home-based therapies, implantable electroceuticals continue to lead the market due to their therapeutic precision and life-saving applications.

Electroceuticals Market- Geographical Insights

Geographically, the Electroceuticals Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America holds the largest share of the global electroceuticals market, with the United States as the primary contributor. The region benefits from a robust healthcare infrastructure, high healthcare spending, and rapid adoption of advanced medical technologies. A rising prevalence of chronic disorders-such as Parkinson's disease, epilepsy, cardiovascular conditions, and hearing loss-drives consistent demand for implantable devices like cardiac pacemakers, ICDs, cochlear implants, and deep brain stimulators. Additionally, the presence of key market players such as Medtronic, Abbott, and Boston Scientific ensures strong research, development, and commercialization pipelines. Regulatory agencies such as the U.S. FDA provide a well-defined framework for medical device approvals, promoting innovation and market entry. Moreover, favorable reimbursement policies and growing physician and patient awareness further support market expansion. The U.S. also leads in clinical trials and academic research focused on neuromodulation and bioelectronic medicine. Canada, while smaller in market size, also contributes through public healthcare initiatives and increased access to advanced treatments. As the region continues to invest in personalized medicine, digital health integration, and miniaturized bioelectronic devices, North America is expected to maintain its leadership in the electroceuticals landscape over the coming years.

Europe stands as the second-largest market for electroceuticals, driven by an aging population and a rising incidence of neurological and cardiovascular disorders. Countries such as Germany, the United Kingdom, and France are major revenue generators due to their advanced healthcare infrastructure, comprehensive insurance coverage, and proactive regulatory support. The region has shown a strong inclination toward adopting innovative therapeutic technologies, including deep brain stimulation, vagus nerve stimulation, and cochlear implants. Europe is home to prominent academic institutions and research centers contributing to bioelectronic medicine development. Funding from both public health bodies and the European Union fosters the growth of clinical research and device innovation. Furthermore, high patient awareness and clinician expertise in neuromodulation therapies bolster adoption rates. Reimbursement frameworks in many European countries support access to high-cost medical technologies, thereby increasing patient uptake of electroceutical treatments.

Electroceuticals Market- Competitive Landscape:

The electroceuticals market is highly competitive, with dominance from established medical device manufacturers such as Medtronic, Boston Scientific Corporation, and Abbott, who leverage extensive R&D capabilities, regulatory expertise, and global distribution networks. These companies focus on expanding their portfolios through innovative solutions in cardiac devices, neuromodulation, and hearing implants. LivaNova Plc, Cochlear Ltd., and Sonova specialize in niche segments like vagus nerve stimulation and cochlear implants, enhancing patient outcomes in neurological and auditory disorders. Meanwhile, emerging players such as Axonics Inc., Neuronetics, ElectroCore Inc., and NeuroPace Inc. are driving innovation through minimally invasive and wearable neuromodulation technologies targeting conditions like depression, epilepsy, and overactive bladder. MicroPort Scientific Corporation and Nervo Corp. are expanding their footprint in Asia and North America, respectively. This competitive landscape, characterized by strategic acquisitions, partnerships, and continuous product development, fosters a dynamic environment that promotes technology advancement and broader adoption of electroceutical therapies worldwide.

Recent Developments:

In April 2024, Axonics Inc. announced FDA approval for its next-generation rechargeable sacral neuromodulation system, offering longer battery life and improved patient comfort.

In January 2024, Boston Scientific Corporation acquired Relievant Medsystems, a company specializing in intraosseous basivertebral nerve ablation therapy, to expand its chronic pain management portfolio.

In November 2023, Abbott received CE Mark approval for its Eterna(TM) spinal cord stimulation system, featuring its smallest implantable rechargeable neurostimulator designed for chronic pain relief.

In September 2023, Neuronetics launched the NeuroStar Advanced Therapy System in new markets across Europe, expanding access to transcranial magnetic stimulation (TMS) for major depressive disorder.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ELECTROCEUTICALS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • Livanova Plc
  • Cochlear Ltd.
  • Microport Scientific Corporation
  • Sonova
  • Nervo Corp.
  • Axonics Inc.
  • Neuronetics
  • Electrocore Inc.
  • Neuropace Inc.
  • Others

GLOBAL ELECTROCEUTICALS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Cardiac Pacemakers & Implantable Cardioverter Defibrillators
  • Cochlear Implants
  • Neuromodulators
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Vagus Nerve Stimulators
  • Sacral Nerve Stimulators
  • Gastric Electrical Stimulators
  • Transcranial Magnetic Stimulators
  • Respiratory Electrical Stimulators
  • Trigeminal Nerve Stimulators
  • Responsive Neurostimulators
  • Retinal Implants

GLOBAL ELECTROCEUTICALS MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

  • Implantable Electroceutical Devices
  • Noninvasive Electroceutical Devices

GLOBAL ELECTROCEUTICALS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cardiac Pacemakers & Implantable Cardioverter Defibrillators
  • Arrhythmia
  • Heart Failure
  • Other Cardiac Pacemaker & Icd Applications
  • Spinal Cord Stimulators
  • Chronic Pain
  • Failed Back Surgery Syndrome
  • Ischemia
  • Deep Brain Stimulators
  • Parkinson's Disease
  • Tremors
  • Depression
  • Other DBS Applications
  • Sacral Nerve Stimulators
  • Urine Incontinence
  • Fecal Incontinence
  • Vagus Nerve Stimulators
  • Epilepsy
  • Other VNS Applications
  • Gastric Electrical Stimulators
  • Gastroparesis
  • Obesity
  • Transcutaneous Electrical Nerve Stimulators
  • Treatment-Resistant Depression
  • Other TENS Application
  • Transcranial Magnetic Stimulators
  • Depression
  • Migraine
  • Respiratory Electrical Stimulators
  • Spinal Cord Injury
  • Trigeminal Nerve Stimulators
  • Attention-Deficit/Hyperactivity Disorder
  • Migraine

GLOBAL ELECTROCEUTICALS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Electroceuticals Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Electroceuticals Market Snippet by Product
    • 2.1.2. Electroceuticals Market Snippet by Type
    • 2.1.3. Electroceuticals Market Snippet by Application
    • 2.1.4. Electroceuticals Market Snippet by Country
    • 2.1.5. Electroceuticals Market Snippet by Region
  • 2.2. Competitive Insights

3. Electroceuticals Key Market Trends

  • 3.1. Electroceuticals Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Electroceuticals Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Electroceuticals Market Opportunities
  • 3.4. Electroceuticals Market Future Trends

4. Electroceuticals Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Electroceuticals Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Electroceuticals Market Landscape

  • 6.1. Electroceuticals Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Electroceuticals Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Cardiac Pacemakers & Implantable Cardioverter Defibrillators
    • 7.1.3. Cochlear Implants
    • 7.1.4. Neuromodulators
      • 7.1.4.1. Spinal Cord Stimulators
      • 7.1.4.2. Deep Brain Stimulators
      • 7.1.4.3. Vagus Nerve Stimulators
      • 7.1.4.4. Sacral Nerve Stimulators
      • 7.1.4.5. Gastric Electrical Stimulators
      • 7.1.4.6. Transcranial Magnetic Stimulators
      • 7.1.4.7. Respiratory Electrical Stimulators
      • 7.1.4.8. Trigeminal Nerve Stimulators
      • 7.1.4.9. Responsive Neurostimulators
    • 7.1.5. Retinal Implants

8. Electroceuticals Market - By Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 8.1.2. Implantable Electroceutical Devices
    • 8.1.3. Non-invasive Electroceutical Devices

9. Electroceuticals Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Cardiac Pacemakers & Implantable Cardioverter Defibrillators
      • 9.1.2.1. Arrhythmia
      • 9.1.2.2. Heart Failure
      • 9.1.2.3. Other Cardiac Pacemaker & Icd Applications
    • 9.1.3. Spinal Cord Stimulators
      • 9.1.3.1. Chronic Pain
      • 9.1.3.2. Failed Back Surgery Syndrome
      • 9.1.3.3. Ischemia
    • 9.1.4. Deep Brain Stimulators
      • 9.1.4.1. Parkinson's Disease
      • 9.1.4.2. Tremors
      • 9.1.4.3. Depression
      • 9.1.4.4. Other Dbs Applications
    • 9.1.5. Sacral Nerve Stimulators
      • 9.1.5.1. Urine Incontinence
      • 9.1.5.2. Fecal Incontinence
    • 9.1.6. Vagus Nerve Stimulators,
      • 9.1.6.1. Epilepsy
      • 9.1.6.2. Other Vns Applications
    • 9.1.7. Gastric Electrical Stimulators
      • 9.1.7.1. Gastroparesis
      • 9.1.7.2. Obesity
    • 9.1.8. Transcutaneous Electrical Nerve Stimulators
      • 9.1.8.1. Treatment-Resistant Depression
      • 9.1.8.2. Other Tens Application
    • 9.1.9. Transcranial Magnetic Stimulators
      • 9.1.9.1. Depression
      • 9.1.9.2. Migraine
    • 9.1.10. Respiratory Electrical Stimulators
      • 9.1.10.1. Spinal Cord Injury
    • 9.1.11. Trigeminal Nerve Stimulators
      • 9.1.11.1. Attention-Deficit/Hyperactivity Disorder
      • 9.1.11.2. Migraine

10. Electroceuticals Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Electroceuticals Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Electroceuticals Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Electroceuticals Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Electroceuticals Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Electroceuticals Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Electroceuticals Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Medtronic
    • 11.2.2. Boston Scientific Corporation
    • 11.2.3. Abbott
    • 11.2.4. Livanova Plc
    • 11.2.5. Cochlear Ltd.
    • 11.2.6. Microport Scientific Corporation
    • 11.2.7. Sonova
    • 11.2.8. Nervo Corp.
    • 11.2.9. Axonics Inc.
    • 11.2.10. Neuronetics
    • 11.2.11. Electrocore Inc.
    • 11.2.12. Neuropace Inc.
    • 11.2.13. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us